References
- K. Schoonjans, B. Staels, J. J. Auwerx, "Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression", Journal of lipid research, Vol.37, No.5 pp. 907-925, (1996). https://doi.org/10.1016/S0022-2275(20)42003-6
- S. A. Kliewer, J. M. Lehmann, T. M. Wilson, "Orphan nuclear receptors: shifting endocrinology into reverse", Science, Vol.284, No.5415 pp. 757-776, (1999). https://doi.org/10.1126/science.284.5415.757
- R. Hertz, J. Bishara-Shieban, J. Bar-Tana, "Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III", The Journal of biological chemistry, Vol.270, No.22 pp. 13470-13475, (1995). https://doi.org/10.1074/jbc.270.22.13470
- T. Osumi, S. Osada, T. Tsukamoto, "Analysis of peroxisome proliferator-responsive enhancer of the rat acyl-CoA oxidase gene", Annals of the New York Academy of Sciences, Vol.804, pp. 202-213, (1996). https://doi.org/10.1111/j.1749-6632.1996.tb18617.x
- K. Schoonjans, J. Peinado-Onsurbe, A. M. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, J. Auwerx, "PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene", The EMBO Journal, Vol.15, No.19 pp. 5336-5348, (1996). https://doi.org/10.1002/j.1460-2075.1996.tb00918.x
-
M. Pawlak, P. Lefebvre, B. Staels B, "Molecular mechanism of PPAR
${\alpha}$ action and its impact on lipid metabolism, imflammation and fibrosis in non-alcoholic fatty liver disease", Journal of Hepatology, Vol.62, No.3 pp. 703-712, (2015). - M. Yoon, S. Jeong, H. Lee, M. Han, J. H. Kang, E. Y. Kim, M. Kim, G. T. Oh, "Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice", Biochemical and biophysical research communications, Vol.302, No.1, pp. 29-34, (2003). https://doi.org/10.1016/S0006-291X(03)00088-3
- E. Chaput, R. Saladin, M. Silvestre, A. D. Edgar, "Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight", Biochemical and biophysical research communications, Vol.271, No.2 pp. 445-450, (2000). https://doi.org/10.1006/bbrc.2000.2647
- M. Carr, "The Emergence of the Metabolic Syndrome with Menopause", The Journal of Clinical Endocrinology and Metabolism, Vol.88, No.6, pp. 2404-2411, (2003). https://doi.org/10.1210/jc.2003-030242
- M. Abbey, A. Owen, M. Suzakawa, P. Roach, P. J. Nestel, "Effects of Menopause and Hormone Replacement Therapy on Plasma Lipids, Lipoproteins and LDL-receptor Activity", Maturitas, Vol.33, No.3 pp. 259-269, (1999). https://doi.org/10.1016/S0378-5122(99)00054-7
- C. J. McAloon, L. M. Boylan, T. Hamborg, N. Stallard, F. Osman, P. B. Lim, S. A. Hayat, "The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data", International Journal of Cardiology, Vol.224, pp. 256-264, (2016). https://doi.org/10.1016/j.ijcard.2016.09.026
- R. A. Lobo, "Benefits and Risks of estrogen replacement therapy", American Journal of Obsterics and Gynecology, Vol.173, No.3 pp. 982-989, (1995). https://doi.org/10.1016/0002-9378(95)90247-3
-
S. Jeong, M. Yoon, "Inhibition of the actions of peroxisome proliferator-activated receptor
${\alpha}$ on obesity by estrogen", Obesity (Silver Spring), Vol.15, No.6 pp. 1430-1440, (2007). https://doi.org/10.1038/oby.2007.171 - S. E. Campbell, K. A. Mehan, R. J. Tunstall, M. A. Febbraio, D. Cameron-Smith, "17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle", Journal of molecular endocrinology, Vol.31, No.1 pp. 37-45, (2003). https://doi.org/10.1677/jme.0.0310037
- D. B. Han, W. A. Payne, E. B. Mauer, Focus on Health (7th ed.), pp. 277-288, Mcgraw-Hill Higher Education, (2005).
- S. Jeong, "Anti-obesity Effects of Genisterin in Female Ovariectomy-induced Obese Mice", Journal of the Korean Applied Science and Technology, Vol.34, No.3 pp. 34-46, (2017).
- M. Yoon, S. Jeong, C. J. Nicol, H. Lee, M. Han, J. J. Kim, Y. J. Seo, C. Ryu, G. T. Oh, "Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism", Experimental and molecular medicine, Vol.34, No.6 pp. 481-488, (2002). https://doi.org/10.1038/emm.2002.67
- S. Jeong, "The Effect of Swimming plus Hypolipidemic Agent on Obesity", Journal of the Korean Applied Science and Technology, Vol.36, No.1 pp. 34-46, (2019). https://doi.org/10.12925/JKOCS.2019.36.1.34
- L. Ning, Y. Liu, W. Wang, Y. Li, L. Chen, Z. Y. Du, "The metabolic regulation of fenofibrate is dependent on dietary protein content in male juveniles of Nile tilapia (Oreochromis niloticus)", The British journal of nutrition, Vol.122, No.6 pp. 648-656, (2019). https://doi.org/10.1017/S0007114519001594
- S. Jeong, M. Han, H. Lee, M. Kim, J. Kim, C. J. Nicol, B. H. Kim, J. H. Choi, K-H Nam, G. T. Oh, M. Yoon, "Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice", Metabolism Vol.53, No.10 pp. 1284-1289, (2004). https://doi.org/10.1016/j.metabol.2004.05.003
- K. Toda, K. Takeda, S. Akira, T. Saibara, T. Okeda, S. Onishi, Y. Shizuta, "Alterations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17 beta-estradiol or a peroxisome proliferator", The Journal of steroid biochemistry and molecular biology, Vol.79, No.1-5 pp. 11-17, (2001). https://doi.org/10.1016/S0960-0760(01)00135-2
-
R. Okazaki, D. Inoue, M. Shibata, M. Saika, S. Kido, H. Ooka, H. Tomiyama, Y. Sakamoto, T. Matsumoto, "Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER)
${\alpha}$ or${\beta}$ ", Endocrinology, Vol.143, No.6, pp. 2349-2356, (2002). https://doi.org/10.1210/endo.143.6.8854